This article is part of a series on Imaging in breast cancer, edited by David A Mankoff.

Editorial

Imaging in breast cancer – breast cancer imaging revisited

David Mankoff

Division of Nuclear Medicine, Department of Radiology, University of Washington and Seattle Cancer Care Alliance, Seattle, WA 98195, USA

author email corresponding author email

Breast Cancer Research 2005, 7:276-278doi:10.1186/bcr1359

Published:	29 November 2005

First paragraph (this article has no abstract)

In 2000, Breast Cancer Research published a series of articles describing the state-of-the-art of breast cancer imaging, edited by James Basilion [1-6]. This series reviewed developments in magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), radionuclide imaging with single-photon emission computed tomography (SPECT) and positron emission tomogrophy (PET), and optical imaging, including optical computed tomography and near infra-red imaging fluorescence. The series had an emphasis on technical development, pre-clinical research, and early clinical studies. Five years later, we revisit the same areas of breast cancer imaging with an eye towards ongoing translational research and new opportunities to detect breast cancer early and to direct effective, individualized therapy.